Loading…
Wednesday September 25, 2024 1:30pm - 2:00pm PDT
  • Discuss the importance of identifying and tailoring metrics to the specific needs and perspectives of various stakeholders within the healthcare ecosystem - both internally, including executive management and cross-functional partners, as well as externally, including providers, payors, and patients. 
  • Highlight the significance of clinically relevant metrics to quantify the impact of Medical Affairs strategic and tactical activities, e.g., educational, and one-on-one field engagement activities that potentially reflect improvement by the medical community's understanding of treatment options and the diagnosis of the therapeutic area. 
  • Explore potential real-world data sources, e.g., electronic health records, claims data, and patient-reported outcomes, in quantifying the impact of Medical Affairs activities. Discuss analytics for effectively capturing, analyzing, and interpreting real-world evidence to potentially explain the meaning of insights and to drive better decision-making around Medical Affairs resource allocation. 
Speakers
avatar for Daniel Snyder, Ph.D.

Daniel Snyder, Ph.D.

Senior Vice President, Head of Medical Affairs, Biopharma & Women’s Health, Sumitomo Pharma America, Inc.
Wednesday September 25, 2024 1:30pm - 2:00pm PDT
San Diego Marriott Del Mar

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link